Generic Ondansetron Injection for Preventing Nausea

The FDA has approved generic versions of GlaxoSmithKline’s ondansetron Zofran Injection and Zofran Injection Premixed. Ondansetron canadian is indicated for preventing chemosurgery-associated and postoperative nausea and vomiting.

The injection (Teva Pharmaceuticals) is available in single (4-mg/2 ml) and multidose (40-mg/20 ml) packages. The premixed product (32 mg/50 ml in 5% dextrose) is manufactured by Sicor Pharmaceuticals.